Genetic Enrichment of Cardiomyocytes Derived from Mouse Embryonic Stem Cells

Wen-Jun He,Shi-Chong Li,Ling-Ling Ye,Hong Liu,Qi-Wei Wang,Wei-Dong Han,Xiao-Bing Fu,Zhao-Lie Chen
DOI: https://doi.org/10.5897/ajb10.2608
2011-01-01
AFRICAN JOURNAL OF BIOTECHNOLOGY
Abstract:Pluripotent embryonic stem cells (ESC) have the ability to differentiate into a variety of cell lineages in vitro , including cardiomyocytes. Successful applications of ESC-derived cardiomyocytes in cell therapy and tissue engineering were limited by difficulties in selecting the desired cells from the heterogeneous cell population. We describe a simple method to generate relatively pure cardiomyocytes from mouse ESCs. A construct comprising mouse cardiac α-myosin heavy chain (MHC) promoter driving the neomycin resistance gene and SV40 promoter driving the hygromycin resistant gene designated pMHCneo/ SV40-hygro, was stably transfected into mouse ESCs. The transgenic ESC line, designated MN6 retained the undifferentiated state and the potential of cardiogenic differentiation. After G418 selection, more than 99% of cells expressed α-sarcomeric actin. Immunocytological and ultrastructural analysis demonstrated that, the selected cardiomyocytes were highly differentiated. Our results represent a simple genetic manipulation used to product essentially pure cardiomyocytes from differentiating ESCs. It may facilitate the development of cell therapy in heart diseases. Key words: Embryonic stem cells, α-myosin heavy chain promoter, cardiomyocytes, differentiation, genetic enrichment.
What problem does this paper attempt to address?